Nivolumab with or Without Chemotherapy for Metastatic Gastroesophageal Cancers and Future Perspectives.
Expert Review of Anticancer Therapy（2022）
Key words
Checkpoint inhibitor,Gastroesophageal Cancer,immunotherapy,nivolumab,PD-1,PD-L1,pembrolizumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined